Skip to main content
# العنوان سنة البحث
621 Serum lipids , Apo E Genotypes and Tumor Necrosis Factor Alpha in Psoriatic Arthritis Patients :In Relation to Disease Activity 2007
622 THE VALUE OF LIPORROTEIN (a), HOMOCYSTEINE AND DOPPLER OF CAROTID AND FEMORAL ARTERIES IN ASSESSMENT OF ATHEROSCLEROSIS ASYMPTOMATIC CARDIOVASCULAR RISK PATIENTS 2007
623 LABORATORY SCREENING FOR RHABDOMYOLYSIS AND REFERENCE LABORATORY VALUES OF MUSCULAR ACTIVITY FOR BEGINNERS PRACTICING VIGOROUS EXERCISES 2007
624 Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity 2007
625 APOLIPORROTEIN E ¾ GENOTYPE AS A CARDIAC RISK MARKER 2007
626 ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA 2007
627 Serum lipids , Apo E Genotypes and Tumor Necrosis Factor Alpha in Psoriatic Arthritis Patients :In Relation to Disease Activity 2007
628 SIGNIFICANCE OF CALCIUM PYROPHOSPHATE DIHYDRATE AND MONOSODIUM URATE CRYSTAL IDENTIFICATION IN SYNOVIAL FLUID OF ARTHRITIC PATIENTS 2007
629 Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity 2007
630 APOLIPORROTEIN E ¾ GENOTYPE AS A CARDIAC RISK MARKER 2007